Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 307

1.

Accuracy of hydrocortisone dose administration via nasogastric tube.

Daniel E, Whitaker MJ, Keevil B, Wales J, Ross RJ.

Clin Endocrinol (Oxf). 2019 Jan;90(1):66-73. doi: 10.1111/cen.13876. Epub 2018 Nov 9.

2.

Salivary Cortisone to Estimate Cortisol Exposure and Sampling Frequency Required Based on Serum Cortisol Measurements.

Harrison RF, Debono M, Whitaker MJ, Keevil BG, Newell-Price J, Ross RJ.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):765-772. doi: 10.1210/jc.2018-01172.

3.

Immediate-release granule formulation of hydrocortisone, AlkindiĀ®, for treatment of paediatric adrenal insufficiency (Infacort development programme).

Porter J, Withe M, Ross RJ.

Expert Rev Endocrinol Metab. 2018 May;13(3):119-124. doi: 10.1080/17446651.2018.1455496. Epub 2018 Mar 26.

PMID:
30058902
4.

Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone.

Johnson TN, Whitaker MJ, Keevil B, Ross RJ.

J Bioequiv Availab. 2018;10(1):001-3. doi: 10.4172/jbb.1000365.

5.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL; Growth Hormone Research Society.

Endocr Connect. 2018 Mar;7(3):R126-R134. doi: 10.1530/EC-18-0047. Epub 2018 Feb 26. Review.

6.

International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen.

Cross AS, Helen Kemp E, White A, Walker L, Meredith S, Sachdev P, Krone NP, Ross RJ, Wright NP, Elder CJ.

Clin Endocrinol (Oxf). 2018 May;88(5):744-751. doi: 10.1111/cen.13559. Epub 2018 Feb 22.

PMID:
29392744
7.

Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia.

Jenkins-Jones S, Parviainen L, Porter J, Withe M, Whitaker MJ, Holden SE, Morgan CL, Currie CJ, Ross RJM.

Eur J Endocrinol. 2018 Apr;178(4):309-320. doi: 10.1530/EJE-17-0895. Epub 2018 Jan 25.

8.

Use of salivary cortisol and cortisone in the high- and low-dose synacthen test.

Elder CJ, Harrison RF, Cross AS, Vilela R, Keevil BG, Wright NP, Ross RJ.

Clin Endocrinol (Oxf). 2018 Jun;88(6):772-778. doi: 10.1111/cen.13509. Epub 2017 Nov 29.

9.

Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency.

Neumann U, Whitaker MJ, Wiegand S, Krude H, Porter J, Davies M, Digweed D, Voet B, Ross RJ, Blankenstein O.

Clin Endocrinol (Oxf). 2018 Jan;88(1):21-29. doi: 10.1111/cen.13447. Epub 2017 Sep 7.

10.

Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.

Melin J, Parra-Guillen ZP, Hartung N, Huisinga W, Ross RJ, Whitaker MJ, Kloft C.

Clin Pharmacokinet. 2018 Apr;57(4):515-527. doi: 10.1007/s40262-017-0575-8.

PMID:
28762136
11.

Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly.

Amarawardena WKMG, Liyanarachchi KD, Newell-Price JDC, Ross RJM, Iacovazzo D, Debono M.

Endocrinol Diabetes Metab Case Rep. 2017 Jul 10;2017. pii: 17-0067. doi: 10.1530/EDM-17-0067. eCollection 2017.

12.

Using approximate Bayesian computation to quantify cell-cell adhesion parameters in a cell migratory process.

Ross RJH, Baker RE, Parker A, Ford MJ, Mort RL, Yates CA.

NPJ Syst Biol Appl. 2017 Mar 10;3:9. doi: 10.1038/s41540-017-0010-7. eCollection 2017.

13.

Synchronous distal phalangeal metastases from primary non-small-cell lung cancer.

Ross RJ, Mann NC.

Lancet. 2017 Jul 22;390(10092):399. doi: 10.1016/S0140-6736(17)31288-6. Epub 2017 May 25. No abstract available.

PMID:
28552369
14.

Quality of compounded hydrocortisone capsules used in the treatment of children.

Neumann U, Burau D, Spielmann S, Whitaker MJ, Ross RJ, Kloft C, Blankenstein O.

Eur J Endocrinol. 2017 Aug;177(2):239-242. doi: 10.1530/EJE-17-0248. Epub 2017 May 16.

15.

Variable species densities are induced by volume exclusion interactions upon domain growth.

Ross RJH, Yates CA, Baker RE.

Phys Rev E. 2017 Mar;95(3-1):032416. doi: 10.1103/PhysRevE.95.032416. Epub 2017 Mar 27.

PMID:
28415323
16.

Verbal memory functioning moderates psychotherapy treatment response for PTSD-Related nightmares.

Scott JC, Harb G, Brownlow JA, Greene J, Gur RC, Ross RJ.

Behav Res Ther. 2017 Apr;91:24-32. doi: 10.1016/j.brat.2017.01.004. Epub 2017 Jan 13.

PMID:
28110112
17.

Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia.

Karunasena N, Margetson DN, Neal G, Whitaker MJ, Ross RJ.

Eur J Endocrinol. 2017 Apr;176(4):405-411. doi: 10.1530/EJE-16-0948. Epub 2017 Jan 18.

18.

Influence of Sleep Disturbance on Global Functioning After Posttraumatic Stress Disorder Treatment.

Brownlow JA, McLean CP, Gehrman PR, Harb GC, Ross RJ, Foa EB.

J Trauma Stress. 2016 Dec;29(6):515-521. doi: 10.1002/jts.22139. Epub 2016 Nov 9.

PMID:
27859588
19.

Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.

Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1797-1806. doi: 10.1210/jc.2016-2855.

20.

A long-acting GH receptor antagonist through fusion to GH binding protein.

Wilkinson IR, Pradhananga SL, Speak R, Artymiuk PJ, Sayers JR, Ross RJ.

Sci Rep. 2016 Oct 12;6:35072. doi: 10.1038/srep35072.

Supplemental Content

Support Center